On March 11, 2025, Zynex reported its fourth quarter and full year 2024 financial results, revealing a significant revenue "shortfall" in the quarter "due to slower than normal payments from certain payers." Zynex further revealed "Tricare has temporarily suspended payments as they review prior claims." Tricare is the health insurance program for the U.S. military. On this news, Zynex's stock price fell $3.59 per share, or 51.3%, to close at $3.41 per share on March 12, 2025. SAN DIEGO, March 31, 2025 /PRNe ...

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139462&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

CLASS PERIOD: March 13, 2023 to March 11, 2025 NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139422& ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, March 28, 2025 /PRNewswire/ -- F ...

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. alleging securities fraud that affected investors between March 13, 2023, and March 11, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2]. - It is alleged that the company's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2]. - The lawsuit suggests that Zynex is likely to face adverse consequences, such as removal from insurer networks and federal penalties, due to these practices [2]. - Defendants' positive statements regarding the company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the specified timeframe have until May 19, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

BENSALEM, Pa., March 27, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI).IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZYNEX, INC. (ZYXI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MAY 19, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of Howard G. Smith ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Zynex, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from March 13, 2023, to March 11, 2025 [1] Allegations - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [1] - It is claimed that Zynex's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [1] - The lawsuit suggests that Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [1] - The positive statements made by the defendants regarding the company's business, operations, and prospects are alleged to be materially misleading and lacking a reasonable basis [1] Next Steps for Shareholders - Shareholders who purchased shares of ZYXI during the specified timeframe are encouraged to register for the class action by May 19, 2025 [2] - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the case [2] - There is no cost or obligation for shareholders to participate in this case [2] About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3] - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities class action lawsuit against Zynex, Inc. (NASDAQ: ZYXI) on behalf of shareholders who purchased stock between March 13, 2023, and March 11, 2025, inclusive. CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION AND JOIN THE CASE •  Lead Plaintiff Deadline: May 19, 2025. •  Allegations: Zynex shipped products, including electrodes, beyond what customers actually needed.This practice inflated the company's r ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action by May 19, 2025 [2][4]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false or misleading statements and failed to disclose critical information, including shipping excess products, inflating revenue, and facing scrutiny from insurers like Tricare [4]. - A report published by medical journal STAT accused Zynex of an "oversupplying scheme," leading to insurers removing the company from their networks [5]. - Following the report, Zynex's stock price dropped by $0.50 per share, or 5%, on June 4, 2024, due to heavy trading volume [5]. Group 2: Financial Performance and Market Reaction - On March 11, 2025, Zynex reported a significant revenue shortfall for Q4 2024, attributing it to slower payments from certain payers and a temporary suspension of payments from Tricare [6]. - The announcement led to a drastic decline in Zynex's stock price, which fell by $3.59 per share, or 51.3%, closing at $3.41 per share on March 12, 2025, amid unusually heavy trading volume [7].

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=138526&from=3 CLASS PERIOD: March 13, 2023 to Marc ...